Current and historical daily PE Ratio for Sprint Bioscience AB (
) from 2014 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sprint Bioscience AB stock (OSTO:SPRINT) PE ratio as of Jun 19 2024 is 12.22.
More Details
Sprint Bioscience AB (OSTO:SPRINT) PE Ratio (TTM) Chart
Sprint Bioscience AB (OSTO:SPRINT) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1280
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Sprint Bioscience AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-19 | 12.2 | 2024-04-12 | 10.5 |
| 2024-06-18 | 12.2 | 2024-04-11 | 11.3 |
| 2024-06-17 | 12.0 | 2024-04-10 | 9.1 |
| 2024-06-14 | 12.5 | 2024-04-09 | 9.2 |
| 2024-06-13 | 13.2 | 2024-04-08 | 9.2 |
| 2024-06-12 | 12.7 | 2024-04-05 | 9.0 |
| 2024-06-11 | 11.9 | 2024-04-04 | 9.3 |
| 2024-06-10 | 11.7 | 2024-04-03 | 9.8 |
| 2024-06-07 | 10.8 | 2024-04-02 | 8.8 |
| 2024-06-05 | 10.8 | 2024-03-28 | 8.6 |
| 2024-06-04 | 10.5 | 2024-03-27 | At Loss |
| 2024-06-03 | 10.4 | 2024-03-26 | At Loss |
| 2024-05-31 | 10.7 | 2024-03-25 | At Loss |
| 2024-05-30 | 10.7 | 2024-03-22 | At Loss |
| 2024-05-29 | 10.7 | 2024-03-21 | At Loss |
| 2024-05-28 | 10.1 | 2024-03-20 | At Loss |
| 2024-05-27 | 10.9 | 2024-03-19 | At Loss |
| 2024-05-24 | 10.5 | 2024-03-18 | At Loss |
| 2024-05-23 | 10.7 | 2024-03-15 | At Loss |
| 2024-05-22 | 10.9 | 2024-03-14 | At Loss |
| 2024-05-21 | 11.6 | 2024-03-13 | At Loss |
| 2024-05-20 | 10.4 | 2024-03-12 | At Loss |
| 2024-05-17 | 10.3 | 2024-03-11 | At Loss |
| 2024-05-16 | 11.1 | 2024-03-08 | At Loss |
| 2024-05-15 | 11.1 | 2024-03-07 | At Loss |
| 2024-05-14 | 10.1 | 2024-03-06 | At Loss |
| 2024-05-13 | 11.2 | 2024-03-05 | At Loss |
| 2024-05-10 | 11.7 | 2024-03-04 | At Loss |
| 2024-05-08 | 11.3 | 2024-03-01 | At Loss |
| 2024-05-07 | 11.3 | 2024-02-29 | At Loss |
| 2024-05-06 | 11.6 | 2024-02-28 | At Loss |
| 2024-05-03 | 11.3 | 2024-02-27 | At Loss |
| 2024-05-02 | 11.0 | 2024-02-26 | At Loss |
| 2024-04-30 | 11.1 | 2024-02-23 | At Loss |
| 2024-04-29 | 10.9 | 2024-02-22 | At Loss |
| 2024-04-26 | 10.8 | 2024-02-21 | At Loss |
| 2024-04-25 | 11.2 | 2024-02-20 | At Loss |
| 2024-04-24 | 11.3 | 2024-02-19 | At Loss |
| 2024-04-23 | 10.8 | 2024-02-16 | At Loss |
| 2024-04-22 | 11.1 | 2024-02-15 | At Loss |
| 2024-04-19 | 11.2 | 2024-02-14 | At Loss |
| 2024-04-18 | 10.4 | 2024-02-13 | At Loss |
| 2024-04-17 | 11.3 | 2024-02-12 | At Loss |
| 2024-04-16 | 11.6 | 2024-02-09 | At Loss |
| 2024-04-15 | 11.0 | 2024-02-08 | At Loss |
Sprint Bioscience AB (OSTO:SPRINT) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sprint Bioscience AB
ISIN : SE0006343745
Compare
Compare
Traded in other countries / regions
SPRINT.Sweden5JA1.Germany IPO Date
2014-11-07Description
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers